Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

ANI Pharmaceuticals

ANI Pharmaceuticals reported $25.72M in EBITDA for its fiscal quarter ending in March of 2023.

Ebitda Change
ANI Pharmaceuticals ANIP:US USD 25.72M 6.76M
Eli Lilly LLY:US USD 1.96B 528.3M
Endo International ENDP:US USD 181.9M 38.32M
Hikma Pharmaceutical HIK:LN USD 350M 1000K
Knight Therapeutics Inc GUD:CN CAD 18.72M 7.18M
Nektar Therapeutics NKTR:US USD -34714000 2.99M
Novartis NVS:US USD 4.72B 217M
Perrigo PRGO:US USD 140.6M 800K
Sun Pharmaceuticals SUNP:IN INR 28.29B 1.78B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 1.08B 226M